Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

111.70
-0.5400-0.48%
Post-market: 111.700.00000.00%18:51 EDT
Volume:453.65K
Turnover:50.79M
Market Cap:5.52B
PE:-19.36
High:113.66
Open:113.06
Low:111.20
Close:112.24
Loading ...
May 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 02, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Major Issues Report

8-K - Current report
Apr 19, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities